451. Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammation.
- Author
-
TIANCHENG XIE, GUANGHUI HU, BINBIN DONG, YANGYE YAN, MIN LIU, XUDONG YAO, JUNHUA ZHENG, and YUNFEI XU
- Subjects
LEYDIG cells ,LIPOPOLYSACCHARIDES ,CYCLIN-dependent kinases ,ANTINEOPLASTIC agents ,ADENOSINES - Abstract
Roscovitine is a cyclin-dependent kinase inhibitor, which has been previously investigated for its anticancer effects. It has also been confirmed that roscovitine can downregulate the expression of myeloid cell leukemia-1 protein to inhibit inflammation. In the present study, roscovitine was used to treat inflammation in lipopolysaccharide (LPS)-induced model mice. At the cellular level, Leydig cells isolated from mouse testis were assessed for inflammatory factors. It was revealed that roscovitine successfully reduced inflammation-associated injury induced by LPS pretreatment. At the molecular level, roscovitine was found to exert this effect through promotion of adenosine monophosphate-activated protein kinase phosphorylation. To the best of our knowledge, the present study was the first to suggest that roscovitine has a protective role in Leydig cells through its anti-inflammatory action. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF